Recent Updates
Recently added Catalysts
COR Positive Sentiment

Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release

Friday, October 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Cencora, Inc. has announced the date for its Fourth Quarter Fiscal 2026 earnings release, scheduled for November 4, 2026. The results will be shared before the market opens, followed by a conference call at 8:30 a.m. ET. Key executives will participate in the call to discuss the financial outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Cencora is set to announce its financial results, indicating business activity.
  • The scheduled conference call allows for direct communication with leadership.
  • The timing of the release aligns with market expectations.

Full Press Release Details

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2026 on Wednesday, November 4, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 4, 2026.Participating in the conference call will be:Robert P. Mauch, President & Chief Executive OfficerEva C. Boratto, Executive Vice President & Chie

Frequently Asked Questions

When will Cencora release its Q4 Fiscal 2026 results?

Cencora will release its Q4 Fiscal 2026 results on November 4, 2026.

What time is the conference call for Cencora's earnings?

The conference call will take place at 8:30 a.m. ET on November 4, 2026.

Who will participate in the Cencora conference call?

Robert P. Mauch and Eva C. Boratto will participate in the call.

What is the significance of the earnings release date?

The earnings release is scheduled before the market opens, aligning with investor expectations.

ShareAdd on Google
Tags: COR Cencora earnings release Fiscal 2026 conference call
Last updated: Oct 2, 2026

Biotech snapshot

Cash runway
$2815M liquidity · $0M/mo burn
Low dilution risk